← 홈

전체 프로그램

ADC 1032 · Antibody 4684 · CGT 2713 · 다음 갱신 D-12 · 마지막 7월 31일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 3,531개
CGTBiologicstaleDigna Biotech S.L.Phase 1

rAAV2/5-PBGD vector dosage 1 (rAAV2/5-PBGD vector dosage 1)

Acute Intermittent Porphyria · Acute Intermittent Porphyria

#AcuteIntermittentPorphyria#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE
CGTBiologicstaleDigna Biotech S.L.Phase 1

rAAV2/5-PBGD vector dosage 2 (rAAV2/5-PBGD vector dosage 2)

Acute Intermittent Porphyria · Acute Intermittent Porphyria

#AcuteIntermittentPorphyria#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE
CGTBiologicstaleDigna Biotech S.L.Phase 1

rAAV2/5-PBGD vector dosage 3 (rAAV2/5-PBGD vector dosage 3)

Acute Intermittent Porphyria · Acute Intermittent Porphyria

#AcuteIntermittentPorphyria#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE
CGTBiologicstaleDigna Biotech S.L.Phase 1

rAAV2/5-PBGD vector dosage 4 (rAAV2/5-PBGD vector dosage 4)

Acute Intermittent Porphyria · Acute Intermittent Porphyria

#AcuteIntermittentPorphyria#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE
CGTBiologicstaleBeacon TherapeuticsPhase 2

rAAV2tYF-CB-hRS1 (rAAV2tYF-CB-hRS1)

X-linked Retinoschisis · X-linked Retinoschisis

#X-linkedRetinoschisis#CGT#Phase2#세포유전치료#CAR-T+2
효능 ORR 39.5%임상시험 1상태 ACTIVE
CGTBiologicstaleBeacon TherapeuticsPhase 3

rAAV2tYF-GRK1-hRPGRco (rAAV2tYF-GRK1-hRPGRco)

X-Linked Retinitis Pigmentosa · X-Linked Retinitis Pigmentosa

#X-LinkedRetinitisPigmentosa#CGT#Phase3#세포유전치료#CAR-T+2
임상시험 1상태 RECRUITING
CGTBiologicstaleBeacon TherapeuticsPhase 2

rAAV2tYF-PR1.7-hCNGB3 (rAAV2tYF-PR1.7-hCNGB3)

Achromatopsia · Achromatopsia

#Achromatopsia#CGT#Phase2#세포유전치료#CAR-T+2
임상시험 1상태 RECRUITING
CGTBiologicstaleEunice Kennedy Shriver National…Phase 1

recombinant adenovirus containing the ornithine transcarbamylase gene (recombinant adenovirus containing the ornithine transcarbamylase gene)

Ornithine Transcarbamylase Deficiency Disease · Ornithine Transcarbamylase Deficiency Di

#OrnithineTranscarbamylaseDeficie#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 DISCONTINUED
AntibodystaleRochePhase 3

recombinant human thrombopoietin (rhTPO, recombinant human thrombopoietin, recombinant human thrombopoietin (rhTPO); rituximab)

Purpura; Idiopathic Thrombocytopenic Purpura · Purpura

#Purpura#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 DISCONTINUED
AntibodystaleThe Affiliated Hospital of Qing…Phase 1

HS627 (recombinant monoclonal antibody against human epidermal growth factor receptor injection, recombinant monoclonal antibody against human epidermal growth factor receptor injection (HS627))

Healthy Volunteers · Healthy Volunteers

#HealthyVolunteers#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleDan LiangPhase 2

adalimumab (Humira, reduction or discontinuation of Adalimumab)

Uveitis; Adalimumab · Uveitis

#Uveitis#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleUniversity of UtahPhase 1

regorafenib + panitumumab (regorafenib + panitumumab)

KRAS and NRAS Wild-type Colorectal Cancer · KRAS and NRAS Wild-type Colorectal Cance

#KRASandNRASWild-typeColorectalCa#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleBristol Myers SquibbPhase 2

nivolumab (Opdivo, relatlimab+nivolumab)

Melanoma · Melanoma

#Melanoma#Antibody#Phase2#항체#면역항체+2
효능 ORR 44.4%임상시험 1상태 ACTIVE
AntibodystaleBristol Myers SquibbPhase 2

nivolumab (Opdivo, relatlimab+nivolumab+rHuPH20)

Melanoma · Melanoma

#Melanoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleJanssenPreclinical

response to infliximab associated with methotrexate (response to infliximab associated with methotrexate)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleGenentech, Inc.Phase 3

ranibizumab (rhuFab V2, rhuFab V2 (ranibizumab))

Macular Degeneration · Macular Degeneration

#MacularDegeneration#Antibody#Phase3#항체#면역항체+2
효능 ORR 56.4%임상시험 1상태 ACTIVE
AntibodystaleRochePhase 3

Bevacizumab (rhuMAb VEGF, rhuMAb VEGF (Bevacizumab))

Renal Cell Cancer · Renal Cell Cancer

#RenalCellCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
ADCBiologicstaleMerck Sharp & Dohme LLCPhase 3

sac-TMT (sac-TMT)

Non-small Cell Lung Cancer; NSCLC · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
CGTBiologicstaleNationwide Children's HospitalPhase 2

scAAV1.tMCK.NTF3 (scAAV1.tMCK.NTF3)

Charcot-Marie-Tooth Neuropathy Type 1A · Charcot-Marie-Tooth Neuropathy Type 1A

#Charcot-Marie-ToothNeuropathyTyp#CGT#Phase2#세포유전치료#CAR-T+2
임상시험 1상태 RECRUITING
CGTBiologicstaleUltragenyx Pharmaceutical IncPhase 2

scAAV8OTC (scAAV8OTC)

Ornithine Transcarbamylase (OTC) Deficiency · Ornithine Transcarbamylase (OTC) Deficie

#OrnithineTranscarbamylaseOTCDefi#CGT#Phase2#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE

175 / 177 페이지

← 이전다음 →